HomeCompareLVZPF vs NOBL

LVZPF vs NOBL: Dividend Comparison 2026

LVZPF yields 2.87% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NOBL wins by $105.00 in total portfolio value· pulled ahead in Year 9
10 years
LVZPF
LVZPF
● Live price
2.87%
Share price
$5.22
Annual div
$0.15
5Y div CAGR
-6.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.7K
Annual income
$164.80
Full LVZPF calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — LVZPF vs NOBL

📍 NOBL pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLVZPFNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LVZPF + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LVZPF pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LVZPF
Annual income on $10K today (after 15% tax)
$244.25/yr
After 10yr DRIP, annual income (after tax)
$140.08/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, NOBL beats the other by $69.18/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LVZPF + NOBL for your $10,000?

LVZPF: 50%NOBL: 50%
100% NOBL50/50100% LVZPF
Portfolio after 10yr
$22.8K
Annual income
$205.49/yr
Blended yield
0.90%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LVZPF buys
0
NOBL buys
0
No recent congressional trades found for LVZPF or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLVZPFNOBL
Forward yield2.87%2.14%
Annual dividend / share$0.15$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-6.7%0%
Portfolio after 10y$22.7K$22.8K
Annual income after 10y$164.80$246.19
Total dividends collected$2.2K$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: LVZPF vs NOBL ($10,000, DRIP)

YearLVZPF PortfolioLVZPF Income/yrNOBL PortfolioNOBL Income/yrGap
1$10,968$268.10$10,914$214.34+$54.00LVZPF
2$11,992$256.41$11,897$218.63+$95.00LVZPF
3$13,076$244.46$12,952$222.72+$124.00LVZPF
4$14,224$232.42$14,086$226.62+$138.00LVZPF
5$15,440$220.45$15,302$230.33+$138.00LVZPF
6$16,730$208.66$16,607$233.85+$123.00LVZPF
7$18,098$197.14$18,007$237.18+$91.00LVZPF
8$19,551$185.96$19,508$240.35+$43.00LVZPF
9← crossover$21,094$175.16$21,116$243.35$22.00NOBL
10$22,736$164.80$22,841$246.19$105.00NOBL

LVZPF vs NOBL: Complete Analysis 2026

LVZPFStock

Livzon Pharmaceutical Group Inc. engages in the research, development, production, and sale of pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People's Republic of China. The company offers Ilaprazole enteric coated tablets for the treatment of duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection; Urofollitropin for injection to treat anovulation and sufferers; Perospirone Hydrochloride for the treatment of schizophrenia; Anti-viral Granules to treat upper respiratory tract infection and influenza; and Shenqi Fuzheng Injection for the treatment of weakness and tiredness, lassitude, spontaneous sweating, and vertigo, as well as for the patients of lung and stomach cancer. It also offers diagnostic reagents, such as diagnostic kit for IgM/IgG antibody to coronavirus; nucleic acid test kit for human immunodeficiency virus type 1; antinuclear antibody test kits; interferon-gamma release assays test kits; and rapid test for mycoplasma pneumoniae IgM antibody. In addition, the company provides biochemical drugs, microbiological preparations, biologic products, Chinese drug preparations and pharmaceutical raw materials, and antibiotics. It also exports its products. The company was founded in 1985 and is headquartered in Zhuhai, China.

Full LVZPF Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this LVZPF vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LVZPF vs SCHDLVZPF vs JEPILVZPF vs OLVZPF vs KOLVZPF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.